WP7: Citizens’ Engagement and Participation

At a glance

The team

A stylised roof with all partner logos for work package 7.

WP7 is led by YCE and contributed to by IACS, HUPON, LIH, INC, CRIHM, SPLS, OIL, CPAS, BIH/CHA, BBMRI-ERIC, DiCE, POLA, ERT, NMC

The task

WP7 is structured around four key tasks:

Task 7.1: Requirements Gathering and Systemic Engagement
Led by YCE (a pan-European patient organisation), this task mobilises 15 consortium members to systematically collect and analyse input from end-users through focus groups and surveys. Regular consultation sessions and design-thinking workshops will identify key needs and concerns.

Task 7.2: Content Review and Patient-Centred Validation
SUHCC (Comprehensive Cancer Centre in Sweden) leads the review of both static and AI-generated content to ensure clarity, relevance, and accessibility for diverse end-users. Feedback from WP7 participants will be integrated, with a focus on lay-language, cultural sensitivity, and individual preferences.

Task 7.3: Validation of EU-CIP Approach
DiCE (a pan-European patient organisation) coordinates the validation process, ensuring that patient and caregiver insights are systematically incorporated into project planning and execution.

Task 7.4: Patient-Centred Participation in Implementation
Piloting sessions will involve end-users in testing and scaling up cancer information portals, starting with a pilot in Lithuania and led by POLA (a national patient organisation). Feedback from these sessions will drive iterative improvements, ensuring that cancer information portals are accessible, user-friendly, and relevant.

Expected Results of WP7:

  • Comprehensive mapping and prioritisation of end-user needs and requirements, validated, patient-friendly content and information algorithms, tailored to diverse user backgrounds and clinical profiles.
  • Systematic integration of end-user feedback into all relevant work packages, resulting in a cohesive and responsive EU-CIP structure.
  • Successful piloting and iterative refinement of national/regional cancer information portals, leading to improved usability, accessibility, and relevance for end-users.
  • Documented impact of patient-driven recommendations, with clear evidence of enhanced user satisfaction, engagement, and trust in the EU-CIP platform.